Quest Introduced First-To-Market Consumer-Initiated Blood Test for Alzheimer's Disease Risk Assessment on Questhealth Website
On July 31, 2023, Quest Diagnostics, a leader in diagnostic information services, announced the introduction of the AD-Detect™ Test for Alzheimer's Disease on questhealth.com – the first blood test available for consumer purchase that helps to assess the potential risk of developing Alzheimer's disease based on a brain protein that contributes to the condition.
Quest introduced the novel innovation in the midst of a rapidly evolving landscape for Alzheimer's disease treatment, which included new and emerging therapies, growing acceptance ...